Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Pecce

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Endocrine|February 27, 2014
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutationCinzia Puppin, Cosimo Durante, Marialuisa Sponziello, et al.
Molecular and Cellular Endocrinology|May 14, 2016
Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cellsMarialuisa Sponziello, Francesca Rosignolo, Marilena Celano, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistanceSofia Trocchianesi, Agnese Po, Anna Citarella, et al.
Endocrine|June 8, 2020
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissueAntonella Verrienti, Valeria Pecce, Luana Abballe, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 7, 2015
A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2Antonella Verrienti, Antonella Carbone, Pasquale Bellitti, et al.
Atherosclerosis|February 6, 2026
The hidden burden of kidney damage in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Endocrine|January 21, 2019
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cellsValentina Maggisano, Marilena Celano, Saverio Massimo Lepore, et al.
International Journal of Oncology|April 11, 2017
MicroRNA-based molecular classification of papillary thyroid carcinomaFrancesca Rosignolo, Lorenzo Memeo, Fabio Monzani, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
Endocrine|April 4, 2015
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cellsMarialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Endocrine|February 27, 2014
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutationCinzia Puppin, Cosimo Durante, Marialuisa Sponziello, et al.
Molecular and Cellular Endocrinology|May 14, 2016
Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cellsMarialuisa Sponziello, Francesca Rosignolo, Marilena Celano, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistanceSofia Trocchianesi, Agnese Po, Anna Citarella, et al.
Endocrine|June 8, 2020
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissueAntonella Verrienti, Valeria Pecce, Luana Abballe, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 7, 2015
A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2Antonella Verrienti, Antonella Carbone, Pasquale Bellitti, et al.
Atherosclerosis|February 6, 2026
The hidden burden of kidney damage in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Endocrine|January 21, 2019
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cellsValentina Maggisano, Marilena Celano, Saverio Massimo Lepore, et al.
International Journal of Oncology|April 11, 2017
MicroRNA-based molecular classification of papillary thyroid carcinomaFrancesca Rosignolo, Lorenzo Memeo, Fabio Monzani, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
Endocrine|April 4, 2015
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cellsMarialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, et al.
Pageof 5